The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease

Journal of Neurosurgery

Volumn 98, Issue 1 SUPPL., 2003, Pages 82-94

  Wanebo, John E ^a,b,c   Lonser, Russell R ^a,b,c   Glenn, Gladys M ^a,b,c   Oldfield, Edward H ^a,b,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Central nervous system; Hemangioblastoma; Neoplasm; Von Hippel Lindau disease

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BRAIN STEM TUMOR; BRAIN TUMOR; CANCER SURGERY; CANCER THERAPY; CENTRAL NERVOUS SYSTEM; CEREBELLUM TUMOR; CONTROLLED STUDY; CYST; DISEASE ASSOCIATION; FEMALE; HEMANGIOBLASTOMA; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD TUMOR; SYMPTOMATOLOGY; SYRINGOMYELIA; TUMOR GROWTH; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

EID: 0037222647     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.1.0082     Document Type: Article

References (48)

1. Anson JA, Ghck RP, Crowell RM: Use of gadolinium-enhanced magnetic resonance imaging in the diagnosis and management of posterior fossa hemangioblastomas. Surg Neurol 35:300-304, 1991
2. Bohling T, Hatva E, Kujala M. et al: Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55:522-527, 1996
3. Brown DF, Gazdar AF, White CL III, et al: Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas. J Neuropathol Exp Neurol 56:1349-1355, 1997
4. Chakraborti PR, Chakrabarti KB, Doughty D, et al: Stereotactic multiple are radiotherapy. IV - Haemangioblastoma. Br J Neurosurg 11:110-115, 1997
5. Chandler HC Jr, Friedman WA: Radiosurgical treatment of a hemangioblastoma: Case report. Neurosurgery 34:353-355, 1994
6. Chen F, Kishida T, Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mutat 5:66-75, 1995
7. Choyke PL, Glenn GM, Walther MM, et al: Von Hippel-Lindau disease: Genetic, clinical, and imaging features. Radiology 194:629-642, 1995
8. Crossey PA, Richards FM, Foster K, et al: Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308, 1994
9. Decker HJ, Weidt EJ, Brieger J: The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet 93:74-83, 1997
10. Filling-Katz MR, Choyke PL, Oldfield E, et al: Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41-46, 1991
11. Filling-Katz MR, Choyke PL, Patronas NJ, et al: Radiologic screening for von Hippel-Lindau disease: The role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr 13:743-755, 1989
12. Glenn GM, Daniel LN, Choyke P, et al: Von Hippel-Lindau (VHL) disease: Distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet 87:207-210, 1991
13. Glenn GM, Linehan WM, Hosoe S, et al: Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 267:1226-1231, 1992
14. Grunberg A, Rodesch G, Hurth M, et al: Imagerie par resonance magnetique des hemangioblastomes intra-rachidiens. Neurochirurgie 40:155-164, 1994
15. Horton WA, Wong V, Eldridge R: Von Hippel-Lindau disease: Clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 136:769-777, 1976
16. Kasarskis EJ, Tibbs PA, Lee C: Cerebellar hemangioblastoma symptomatic during pregnancy. Neurosurgery 22:770-772, 1988
17. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, Ed 2. Berlin: Springer-Verlag, 1993, pp 41-42
18. Knudson AG Jr: Genetics of human cancer. Annu Rev Genet 20:231-251, 1986
19. Knudson AG Jr, Strong LC: Mutation and cancer: Neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514-532, 1972
20. Lamiell JM, Salazar FG, Hsia YE: Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68:1-29, 1989
21. Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993
22. Lonser RR, Weil RJ, Wanebo JE, et al: Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98:106-116, 2003
23. Lundin P, Pedersen F: Volume of pituitary macroadenomas: Assessment by MRI. J Comput Assist Tomogr 16:519-528, 1992
24. Maddock IR, Moran A, Maher ER, et al: A genetic register for von Hippel-Lindau disease. J Med Genet 33:120-127, 1996
25. Maher ER, Iselius L, Yates JR, et al: Von Hippel-Lindau disease: A genetic study. J Med Genet 28:443-447, 1991
26. Maher ER, Webster AR, Moore AT: Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79-84, 1995
27. Maher ER, Yates JRW, Harries R, et al: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-1163, 1990
28. Melmon KL, Rosen SW: Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595-617, 1964
29. Nathan L, Satin AJ, Twickler DM: Cerebellar hemangioblastoma complicating pregnancy. A case report. J Reprod Med 40:662-664, 1995
30. Neumann HP, Eggert HR, Scheremet R, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898-901, 1992
31. Neumann HP, Eggert HR, Weigel K, et al: Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24-30, 1989
32. Niemela M, Lim YJ, Soderman M, et al: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591-596, 1996
33. Page KA, Wayson K, Steinberg GK, et al: Stereotaxic radiosurgical ablation: An alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases. Surg Neurol 40:424-428, 1993
34. Palmer JJ: Haemangioblastomas. A review of 81 cases. Acta Neurochir 27:125-148, 1972
35. Patrice SJ, Sneed PK, Flickinger JC, et al: Radiosurgery for hemangioblastoma: Results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys 35:493-499, 1996
36. Pluta RM, Iuliano B, DeVroom HL, et al: Comparison of anterior and posterior surgical approaches in the treatment of ventral spinal hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98:117-124, 2003
37. Richards FM, Crossey PA, Phipps ME, et al: Detailed mapping of germline deletions of the von Hippel-Lindau disease tumor suppressor gene. Hum Mol Genet 3:595-598, 1994
38. Robinson RG: Aspects of the natural history of cerebellar hemangioblastomas. Acta Neurol Scand 41:372-380, 1966
39. Stolle C, Glenn G, Zbar B, et al: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423, 1998
40. Stratmann R, Krieg M, Haas R, et al: Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 56:1242-1252, 1997
41. Sung DI, Chang CH, Harisiadis L: Cerebellar hemangioblastomas. Cancer 49:553-555, 1982
42. Thomsen J, Tos M: Acoustic neuroma: Clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol 11:12-19, 1990
43. Wazen J, Silverstein H, Norrell H, et al: Preoperative and postoperative growth rates in acoustic neuromas documented with CT scanning. Otolaryngol Head Neck Surg 93:151-155, 1985
44. Weil RJ, Lonser RR, DeVroom HL, et al: Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98:95-105, 2003
45. Whaley JM, Naglich J, Gelbert L, et al: Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092-1102, 1994
46. Wizigmann-Voos S, Breier G, Risau W, et al: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358-1364, 1995
47. Yamamoto M, Jimbo M, Ide M, et al: Is unchanged tumor volume after radiosurgery a measure of outcome? Stereotact Funct Neurosurg 66 (Suppl 1):231-239, 1996
48. Zbar B, Kishida T, Chen F, et al: Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348-357, 1996